Experts demand urgent reform of Spain’s ‘predatory’ tax bonuses and crippling litigation rules
When public policy instruments cease to serve the common good and instead become tools for aggressive capital extraction,…
Novo Nordisk Balances a $25M Ransom Demand and a High-Stakes FDA Decision as Shares Rebound
Novo Nordisk has clawed back more than a third of its value from March lows, yet the Danish…
Novo Nordisk Outruns $75 Million Ransomware Demand With Oral Wegovy Scripts and a China Gambit
Novo Nordisk finds itself waging a war on two fronts this week. While two separate cybercriminal groups —…
Novo Nordisk Battles Legal Setback and Pill Demand Slowdown as European Expansion Looms
Danish pharma giant faces Supreme Court pricing blow, Wegovy script slowdown, and Eli Lilly rivalry as Q1 revenue…
Ryanair Launches High-Demand Routes from Glasgow Airport
Quick Summary Ryanair adds two major European corridors from Glasgow Airport as of March 2026 New direct flights…
Novo Nordisk’s Wegovy® Pill Achieves Strong First-Month Uptake, Signaling Expanding Demand for Oral GLP-1s in Obesity
Awareness and prescribing of the Wegovy pill for weight loss surge among primary care physicians and endocrinologists following…